Zacks Research Expects Lower Earnings for Encompass Health

Encompass Health Co. (NYSE:EHC) – Investment analysts at Zacks Research cut their Q4 2025 earnings estimates for Encompass Health in a research report issued on Wednesday, January 8th. Zacks Research analyst Z. Masood now expects that the company will earn $1.14 per share for the quarter, down from their prior forecast of $1.15. The consensus estimate for Encompass Health’s current full-year earnings is $4.29 per share. Zacks Research also issued estimates for Encompass Health’s Q2 2026 earnings at $1.40 EPS.

EHC has been the subject of several other research reports. Royal Bank of Canada increased their price objective on shares of Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a report on Wednesday, October 30th. UBS Group lifted their price objective on shares of Encompass Health from $100.00 to $110.00 and gave the stock a “buy” rating in a research note on Wednesday, September 25th. Truist Financial reiterated a “buy” rating and set a $116.00 price target (up from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Barclays raised their price objective on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 29th. Finally, KeyCorp upped their price objective on Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research report on Tuesday, October 29th. Nine equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $107.11.

Encompass Health Stock Up 1.3 %

Shares of EHC opened at $92.78 on Friday. Encompass Health has a 12-month low of $67.43 and a 12-month high of $104.55. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. The company has a market capitalization of $9.35 billion, a PE ratio of 22.41, a price-to-earnings-growth ratio of 1.30 and a beta of 0.89. The business’s 50 day moving average is $98.39 and its 200 day moving average is $93.61.

Encompass Health (NYSE:EHC) last issued its quarterly earnings results on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, beating the consensus estimate of $0.94 by $0.09. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The business had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.33 billion. The company’s revenue for the quarter was up 11.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.86 earnings per share.

Institutional Investors Weigh In On Encompass Health

A number of large investors have recently bought and sold shares of the company. Commonwealth Equity Services LLC raised its holdings in shares of Encompass Health by 1.3% during the second quarter. Commonwealth Equity Services LLC now owns 9,845 shares of the company’s stock worth $845,000 after purchasing an additional 123 shares during the last quarter. Los Angeles Capital Management LLC purchased a new position in Encompass Health during the second quarter valued at approximately $682,000. Acadian Asset Management LLC acquired a new stake in shares of Encompass Health during the 2nd quarter worth approximately $901,000. Daiwa Securities Group Inc. acquired a new position in shares of Encompass Health in the second quarter worth about $60,000. Finally, HHM Wealth Advisors LLC acquired a new stake in Encompass Health in the second quarter valued at approximately $146,000. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Encompass Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be paid a dividend of $0.17 per share. The ex-dividend date is Thursday, January 2nd. This represents a $0.68 annualized dividend and a yield of 0.73%. Encompass Health’s payout ratio is presently 16.43%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.